Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study finds.These adverse events included hospitalization, disability, and in a few cases, death.  Researchers found that mature generic drugs, those that had been o...